Extended Data Fig. 8: The histopathological study of orthotopic KPC-Luc tumors after being treated with CD47p/GEM/AZE-Paclitaxome-2. | Nature Cancer

Extended Data Fig. 8: The histopathological study of orthotopic KPC-Luc tumors after being treated with CD47p/GEM/AZE-Paclitaxome-2.

From: A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer

Extended Data Fig. 8: The histopathological study of orthotopic KPC-Luc tumors after being treated with CD47p/GEM/AZE-Paclitaxome-2.

Representative IHC staining for intratumoral γ-H2AX, HO-1, CDA, CC-3 (scale bar: 100 μm) and immunofluorescence staining for β-tubulin (scale bar: 50 μm) in orthotopic KPC-Luc tumors from Fig. 7n. (n = 5 tumors per group).

Source data

Back to article page